Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Melinta Therapeutics, Inc. (NASDAQ:MLNT)

14.40
Delayed Data
As of 4:12pm ET
 -0.55 / -3.68%
Today’s Change
10.25
Today|||52-Week Range
39.25
+2.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues7.8M15.2M27.3M18.0M
 
 
 
 
 
Depreciation And Amortization39.6K76.3K69.2K51.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses50.7M74.5M116.2M135.2M
 
 
 
 
 
Research And Development41.3M62.5M93.4M81.7M
 
 
 
 
 
Total Operating Expenses50.7M74.6M116.2M135.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-42.9M-59.4M-88.9M-117.2M
 
 
 
 
 
Extraordinary Credit--119.7K0.000.00
 
 
Extraordinary Charge-217.4K0.000.000.00
 
 
Interest Expense On Debt1.9M2.4M2.2M1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-45.0M-61.6M-91.1M-118.0M
 
 
 
 
 
Net Income-45.0M-61.6M-91.1M-118.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.9M6.8M8.7M10.1M
 
 
 
 
 
Shares To Calculate EPS Diluted5.9M6.8M8.7M10.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$7.65-$9.05-$10.45-$11.70
 
 
 
 
 
EPS Diluted-$7.65-$9.05-$10.45-$11.70